Uncategorized files

Showing below up to 50 results in range #22,201 to #22,250.

• 
  Epinephrine02.png 1,149 × 1,199; 660 KB
  
• 
  Epinephrine03.png 1,290 × 1,537; 823 KB
  
• 
  Epinephrine04.png 1,542 × 1,405; 205 KB
  
• 
  Epinephrine Str.png 283 × 238; 22 KB
  
• 
  Epinephrine aerosal how to use.png 151 × 91; 10 KB
  
• 
  Epinephrine structure.png 426 × 288; 6 KB
  
• 
  Epipen.jpg 500 × 120; 10 KB
  
• 
  Epiploic-appendagitis-001.jpg 512 × 512; 61 KB
  
• 
  Epiploic-appendagitis-002.jpg 512 × 512; 61 KB
  
• 
  Epiploic-appendagitis-003.jpg 512 × 512; 61 KB
  
• 
  Epiploic-appendagitis-004.jpg 512 × 512; 49 KB
  
• 
  Epiploic appendagitis CT 001.jpg 689 × 600; 41 KB
  
• 
  Epiploic appendagitis CT 002.jpg 689 × 600; 32 KB
  
• 
  Epiploic appendagitis CT 003.jpg 554 × 600; 43 KB
  
• 
  Epiploic appendagitis CT 004.jpg 554 × 600; 31 KB
  
• 
  Epirubicin.png 240 × 164; 2 KB
  
• 
  Epirubicin00.png 298 × 1,113; 54 KB
  
• 
  Epirubicin01.png 342 × 200; 29 KB
  
• 
  Epirubicin010.png 647 × 298; 118 KB
  
• 
  Epirubicin02.png 592 × 272; 21 KB
  
• 
  Epirubicin03.png 633 × 1,194; 85 KB
  
• 
  Epirubicin04.png 503 × 364; 23 KB
  
• 
  Epirubicin05.png 415 × 250; 45 KB
  
• 
  Epirubicin06.png 631 × 852; 112 KB
  
• 
  Epirubicin07.png 635 × 431; 41 KB
  
• 
  Epirubicin08.png 629 × 731; 76 KB
  
• 
  Epirubicin09.png 642 × 3,016; 354 KB
  
• 
  Epirubicin10.png 338 × 142; 7 KB
  
• 
  Epirubicin11.png 675 × 683; 137 KB
  
• 
  Epirubicin12.png 645 × 339; 120 KB
  
• 
  Epirubicin13.png 649 × 667; 146 KB
  
• 
  Epirubicin14.png 628 × 2,939; 176 KB
  
• 
  Epirubicin hydrochloride 200 mg.png 638 × 330; 167 KB
  
• 
  Epirubicin hydrochloride 200 mg FDA package label.png 621 × 1,183; 102 KB
  
• 
  Epirubicin hydrochloride 50 mg.png 640 × 287; 163 KB
  
• 
  Epirubicin hydrochloride 50 mg FDA package label.png 617 × 931; 82 KB
  
• 
  Epirubicin hydrochloride Clinically Relevant Acute Adverse Events in Patients with Early Breast Cancer.png 628 × 1,331; 125 KB
  
• 
  Epirubicin hydrochloride Efficacy Results from Phase 3 Studies of Patients with Early Breast Cancer.png 632 × 876; 112 KB
  
• 
  Epirubicin hydrochloride Kaplan-Meier curves.png 545 × 2,040; 257 KB
  
• 
  Epirubicin hydrochloride Long-Term Adverse Events in Patients with Early Breast Cancer.png 486 × 366; 31 KB
  
• 
  Epirubicin hydrochloride Treatment Regimens Used in Phase 3 Studies of Patients with Early Breast Cancer.png 627 × 737; 100 KB
  
• 
  Epirubicin hydrochloride chemical structure.png 335 × 194; 25 KB
  
• 
  Epirubicin hydrochloride pharmacokinetic.png 651 × 415; 53 KB
  
• 
  Epirubicin hydrochloride structure.png 265 × 317; 28 KB
  
• 
  Episl2.gif 500 × 333; 40 KB
  
• 
  Episl4.gif 500 × 333; 29 KB
  
• 
  Episl5.gif 500 × 333; 40 KB
  
• 
  Epispadia.jpg 400 × 600; 17 KB
  
• 
  Epispadias-001.jpg 385 × 599; 19 KB
  
• 
  Epithelial-cells.jpg 202 × 202; 46 KB